Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
4.010
+0.410 (11.39%)
At close: Dec 5, 2025, 4:00 PM EST
3.990
-0.020 (-0.50%)
After-hours: Dec 5, 2025, 7:57 PM EST
Quince Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -56.98 | -56.83 | -31.39 | -51.66 | -89.95 | -76.85 | |
| Depreciation & Amortization | 0.12 | 0.19 | 0.32 | 0.2 | 0.34 | 0.33 | |
| Loss (Gain) From Sale of Assets | - | - | -0.04 | 0.09 | - | - | |
| Asset Writedown & Restructuring Costs | - | 17.13 | 5.97 | 0.96 | - | - | |
| Loss (Gain) From Sale of Investments | -1.32 | -2.35 | -2.02 | -0.11 | 0.88 | 0.64 | |
| Stock-Based Compensation | 5.04 | 4.75 | 5.22 | 16.62 | 29.85 | 14.47 | |
| Other Operating Activities | 12.37 | 5.69 | 1.67 | -0.31 | 0.2 | 0.37 | |
| Change in Accounts Payable | 1.57 | 0.93 | -0.29 | -5.94 | 1.36 | 0.48 | |
| Change in Other Net Operating Assets | 0.7 | -1.41 | 2.27 | -3.89 | -5.62 | 9.75 | |
| Operating Cash Flow | -38.5 | -31.9 | -18.29 | -44.04 | -62.93 | -50.82 | |
| Capital Expenditures | -0.48 | -0.26 | -0.16 | -0.13 | -0.18 | -0.05 | |
| Sale of Property, Plant & Equipment | - | - | 0.09 | 0.07 | - | - | |
| Cash Acquisitions | - | - | -2.12 | 10.59 | - | - | |
| Investment in Securities | 26.5 | 22.17 | -2.57 | 7.47 | 59.13 | -52.38 | |
| Other Investing Activities | - | - | -1 | - | - | - | |
| Investing Cash Flow | 26.02 | 21.91 | -5.76 | 18 | 58.95 | -52.43 | |
| Long-Term Debt Repaid | - | - | -0.01 | -0.05 | - | -0.03 | |
| Net Debt Issued (Repaid) | - | - | -0.01 | -0.05 | - | -0.03 | |
| Issuance of Common Stock | 15.88 | 0.23 | 0.15 | 0.76 | 6.81 | 118.91 | |
| Other Financing Activities | - | -5 | - | - | - | - | |
| Financing Cash Flow | 15.88 | -4.78 | 0.14 | 0.71 | 6.81 | 118.88 | |
| Foreign Exchange Rate Adjustments | 0.38 | 0.23 | 0.08 | 0.18 | 0.06 | - | |
| Net Cash Flow | 3.78 | -14.54 | -23.83 | -25.15 | 2.88 | 15.63 | |
| Free Cash Flow | -38.98 | -32.16 | -18.45 | -44.17 | -63.11 | -50.87 | |
| Free Cash Flow Per Share | -0.83 | -0.74 | -0.50 | -1.32 | -2.12 | -1.74 | |
| Levered Free Cash Flow | -17.98 | -19.57 | -1.94 | -24.18 | -30.54 | -24.54 | |
| Unlevered Free Cash Flow | -17.41 | -19.57 | -1.94 | -24.18 | -30.54 | -24.54 | |
| Change in Working Capital | 2.27 | -0.48 | 1.98 | -9.83 | -4.26 | 10.23 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.